Medical Care

Global Human Microbiome Sequencing Market Research Report 2024

The global Human Microbiome Sequencing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Human Microbiome Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Microbiome Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Human Microbiome Sequencing in Genome Analysis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Human Microbiome Sequencing include Baseclear B.V., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Charles River Laboratories International Inc., Clinical Microbiomics A/S, Eurofins Scientific SE, GENEWIZ, Inc., Illumina, Inc., Novogene Corporation and OraSure Technologies, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Microbiome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Microbiome Sequencing.
Report Scope
The Human Microbiome Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Microbiome Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Microbiome Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baseclear B.V.
Beijing Genomics Institute (BGI) Genomics Co., Ltd
Charles River Laboratories International Inc.
Clinical Microbiomics A/S
Eurofins Scientific SE
GENEWIZ, Inc.
Illumina, Inc.
Novogene Corporation
OraSure Technologies, Inc.
Oxford Nanopore Technologies, Inc.
Pacific Biosciences of California, Inc.
QIAGEN N.V.
Second Genome, Inc.
Thermo Fisher Scientific Inc.
Viome, Inc.
CosmosID
Leucine Rich Bio Pvt. Ltd.
Microba
Microbiome Insights Inc.
Molzym GmbH & Co. KG
Segment by Type
Next-Generation Sequencing
Traditional Sequencing Technologies
Other
Segment by Application
Genome Analysis
Metabolome Analysis
Transcriptome Analysis
Other Omics Analysis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Microbiome Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Microbiome Sequencing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Next-Generation Sequencing
1.2.3 Traditional Sequencing Technologies
1.2.4 Other
1.3 Market by Application
1.3.1 Global Human Microbiome Sequencing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Genome Analysis
1.3.3 Metabolome Analysis
1.3.4 Transcriptome Analysis
1.3.5 Other Omics Analysis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Sequencing Market Perspective (2019-2030)
2.2 Human Microbiome Sequencing Growth Trends by Region
2.2.1 Global Human Microbiome Sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Microbiome Sequencing Historic Market Size by Region (2019-2024)
2.2.3 Human Microbiome Sequencing Forecasted Market Size by Region (2025-2030)
2.3 Human Microbiome Sequencing Market Dynamics
2.3.1 Human Microbiome Sequencing Industry Trends
2.3.2 Human Microbiome Sequencing Market Drivers
2.3.3 Human Microbiome Sequencing Market Challenges
2.3.4 Human Microbiome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Microbiome Sequencing Players by Revenue
3.1.1 Global Top Human Microbiome Sequencing Players by Revenue (2019-2024)
3.1.2 Global Human Microbiome Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global Human Microbiome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Microbiome Sequencing Revenue
3.4 Global Human Microbiome Sequencing Market Concentration Ratio
3.4.1 Global Human Microbiome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Sequencing Revenue in 2023
3.5 Human Microbiome Sequencing Key Players Head office and Area Served
3.6 Key Players Human Microbiome Sequencing Product Solution and Service
3.7 Date of Enter into Human Microbiome Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Sequencing Breakdown Data by Type
4.1 Global Human Microbiome Sequencing Historic Market Size by Type (2019-2024)
4.2 Global Human Microbiome Sequencing Forecasted Market Size by Type (2025-2030)
5 Human Microbiome Sequencing Breakdown Data by Application
5.1 Global Human Microbiome Sequencing Historic Market Size by Application (2019-2024)
5.2 Global Human Microbiome Sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Microbiome Sequencing Market Size (2019-2030)
6.2 North America Human Microbiome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Microbiome Sequencing Market Size by Country (2019-2024)
6.4 North America Human Microbiome Sequencing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Microbiome Sequencing Market Size (2019-2030)
7.2 Europe Human Microbiome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Microbiome Sequencing Market Size by Country (2019-2024)
7.4 Europe Human Microbiome Sequencing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Microbiome Sequencing Market Size (2019-2030)
8.2 Asia-Pacific Human Microbiome Sequencing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Microbiome Sequencing Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Microbiome Sequencing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Microbiome Sequencing Market Size (2019-2030)
9.2 Latin America Human Microbiome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Microbiome Sequencing Market Size by Country (2019-2024)
9.4 Latin America Human Microbiome Sequencing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Microbiome Sequencing Market Size (2019-2030)
10.2 Middle East & Africa Human Microbiome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Microbiome Sequencing Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Microbiome Sequencing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baseclear B.V.
11.1.1 Baseclear B.V. Company Detail
11.1.2 Baseclear B.V. Business Overview
11.1.3 Baseclear B.V. Human Microbiome Sequencing Introduction
11.1.4 Baseclear B.V. Revenue in Human Microbiome Sequencing Business (2019-2024)
11.1.5 Baseclear B.V. Recent Development
11.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd
11.2.1 Beijing Genomics Institute (BGI) Genomics Co., Ltd Company Detail
11.2.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd Business Overview
11.2.3 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Introduction
11.2.4 Beijing Genomics Institute (BGI) Genomics Co., Ltd Revenue in Human Microbiome Sequencing Business (2019-2024)
11.2.5 Beijing Genomics Institute (BGI) Genomics Co., Ltd Recent Development
11.3 Charles River Laboratories International Inc.
11.3.1 Charles River Laboratories International Inc. Company Detail
11.3.2 Charles River Laboratories International Inc. Business Overview
11.3.3 Charles River Laboratories International Inc. Human Microbiome Sequencing Introduction
11.3.4 Charles River Laboratories International Inc. Revenue in Human Microbiome Sequencing Business (2019-2024)
11.3.5 Charles River Laboratories International Inc. Recent Development
11.4 Clinical Microbiomics A/S
11.4.1 Clinical Microbiomics A/S Company Detail
11.4.2 Clinical Microbiomics A/S Business Overview
11.4.3 Clinical Microbiomics A/S Human Microbiome Sequencing Introduction
11.4.4 Clinical Microbiomics A/S Revenue in Human Microbiome Sequencing Business (2019-2024)
11.4.5 Clinical Microbiomics A/S Recent Development
11.5 Eurofins Scientific SE
11.5.1 Eurofins Scientific SE Company Detail
11.5.2 Eurofins Scientific SE Business Overview
11.5.3 Eurofins Scientific SE Human Microbiome Sequencing Introduction
11.5.4 Eurofins Scientific SE Revenue in Human Microbiome Sequencing Business (2019-2024)
11.5.5 Eurofins Scientific SE Recent Development
11.6 GENEWIZ, Inc.
11.6.1 GENEWIZ, Inc. Company Detail
11.6.2 GENEWIZ, Inc. Business Overview
11.6.3 GENEWIZ, Inc. Human Microbiome Sequencing Introduction
11.6.4 GENEWIZ, Inc. Revenue in Human Microbiome Sequencing Business (2019-2024)
11.6.5 GENEWIZ, Inc. Recent Development
11.7 Illumina, Inc.
11.7.1 Illumina, Inc. Company Detail
11.7.2 Illumina, Inc. Business Overview
11.7.3 Illumina, Inc. Human Microbiome Sequencing Introduction
11.7.4 Illumina, Inc. Revenue in Human Microbiome Sequencing Business (2019-2024)
11.7.5 Illumina, Inc. Recent Development
11.8 Novogene Corporation
11.8.1 Novogene Corporation Company Detail
11.8.2 Novogene Corporation Business Overview
11.8.3 Novogene Corporation Human Microbiome Sequencing Introduction
11.8.4 Novogene Corporation Revenue in Human Microbiome Sequencing Business (2019-2024)
11.8.5 Novogene Corporation Recent Development
11.9 OraSure Technologies, Inc.
11.9.1 OraSure Technologies, Inc. Company Detail
11.9.2 OraSure Technologies, Inc. Business Overview
11.9.3 OraSure Technologies, Inc. Human Microbiome Sequencing Introduction
11.9.4 OraSure Technologies, Inc. Revenue in Human Microbiome Sequencing Business (2019-2024)
11.9.5 OraSure Technologies, Inc. Recent Development
11.10 Oxford Nanopore Technologies, Inc.
11.10.1 Oxford Nanopore Technologies, Inc. Company Detail
11.10.2 Oxford Nanopore Technologies, Inc. Business Overview
11.10.3 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Introduction
11.10.4 Oxford Nanopore Technologies, Inc. Revenue in Human Microbiome Sequencing Business (2019-2024)
11.10.5 Oxford Nanopore Technologies, Inc. Recent Development
11.11 Pacific Biosciences of California, Inc.
11.11.1 Pacific Biosciences of California, Inc. Company Detail
11.11.2 Pacific Biosciences of California, Inc. Business Overview
11.11.3 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Introduction
11.11.4 Pacific Biosciences of California, Inc. Revenue in Human Microbiome Sequencing Business (2019-2024)
11.11.5 Pacific Biosciences of California, Inc. Recent Development
11.12 QIAGEN N.V.
11.12.1 QIAGEN N.V. Company Detail
11.12.2 QIAGEN N.V. Business Overview
11.12.3 QIAGEN N.V. Human Microbiome Sequencing Introduction
11.12.4 QIAGEN N.V. Revenue in Human Microbiome Sequencing Business (2019-2024)
11.12.5 QIAGEN N.V. Recent Development
11.13 Second Genome, Inc.
11.13.1 Second Genome, Inc. Company Detail
11.13.2 Second Genome, Inc. Business Overview
11.13.3 Second Genome, Inc. Human Microbiome Sequencing Introduction
11.13.4 Second Genome, Inc. Revenue in Human Microbiome Sequencing Business (2019-2024)
11.13.5 Second Genome, Inc. Recent Development
11.14 Thermo Fisher Scientific Inc.
11.14.1 Thermo Fisher Scientific Inc. Company Detail
11.14.2 Thermo Fisher Scientific Inc. Business Overview
11.14.3 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Introduction
11.14.4 Thermo Fisher Scientific Inc. Revenue in Human Microbiome Sequencing Business (2019-2024)
11.14.5 Thermo Fisher Scientific Inc. Recent Development
11.15 Viome, Inc.
11.15.1 Viome, Inc. Company Detail
11.15.2 Viome, Inc. Business Overview
11.15.3 Viome, Inc. Human Microbiome Sequencing Introduction
11.15.4 Viome, Inc. Revenue in Human Microbiome Sequencing Business (2019-2024)
11.15.5 Viome, Inc. Recent Development
11.16 CosmosID
11.16.1 CosmosID Company Detail
11.16.2 CosmosID Business Overview
11.16.3 CosmosID Human Microbiome Sequencing Introduction
11.16.4 CosmosID Revenue in Human Microbiome Sequencing Business (2019-2024)
11.16.5 CosmosID Recent Development
11.17 Leucine Rich Bio Pvt. Ltd.
11.17.1 Leucine Rich Bio Pvt. Ltd. Company Detail
11.17.2 Leucine Rich Bio Pvt. Ltd. Business Overview
11.17.3 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Introduction
11.17.4 Leucine Rich Bio Pvt. Ltd. Revenue in Human Microbiome Sequencing Business (2019-2024)
11.17.5 Leucine Rich Bio Pvt. Ltd. Recent Development
11.18 Microba
11.18.1 Microba Company Detail
11.18.2 Microba Business Overview
11.18.3 Microba Human Microbiome Sequencing Introduction
11.18.4 Microba Revenue in Human Microbiome Sequencing Business (2019-2024)
11.18.5 Microba Recent Development
11.19 Microbiome Insights Inc.
11.19.1 Microbiome Insights Inc. Company Detail
11.19.2 Microbiome Insights Inc. Business Overview
11.19.3 Microbiome Insights Inc. Human Microbiome Sequencing Introduction
11.19.4 Microbiome Insights Inc. Revenue in Human Microbiome Sequencing Business (2019-2024)
11.19.5 Microbiome Insights Inc. Recent Development
11.20 Molzym GmbH & Co. KG
11.20.1 Molzym GmbH & Co. KG Company Detail
11.20.2 Molzym GmbH & Co. KG Business Overview
11.20.3 Molzym GmbH & Co. KG Human Microbiome Sequencing Introduction
11.20.4 Molzym GmbH & Co. KG Revenue in Human Microbiome Sequencing Business (2019-2024)
11.20.5 Molzym GmbH & Co. KG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Human Microbiome Sequencing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Next-Generation Sequencing
Table 3. Key Players of Traditional Sequencing Technologies
Table 4. Key Players of Other
Table 5. Global Human Microbiome Sequencing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Human Microbiome Sequencing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Human Microbiome Sequencing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Human Microbiome Sequencing Market Share by Region (2019-2024)
Table 9. Global Human Microbiome Sequencing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Human Microbiome Sequencing Market Share by Region (2025-2030)
Table 11. Human Microbiome Sequencing Market Trends
Table 12. Human Microbiome Sequencing Market Drivers
Table 13. Human Microbiome Sequencing Market Challenges
Table 14. Human Microbiome Sequencing Market Restraints
Table 15. Global Human Microbiome Sequencing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Human Microbiome Sequencing Market Share by Players (2019-2024)
Table 17. Global Top Human Microbiome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Sequencing as of 2023)
Table 18. Ranking of Global Top Human Microbiome Sequencing Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Human Microbiome Sequencing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Human Microbiome Sequencing Product Solution and Service
Table 22. Date of Enter into Human Microbiome Sequencing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Human Microbiome Sequencing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Human Microbiome Sequencing Revenue Market Share by Type (2019-2024)
Table 26. Global Human Microbiome Sequencing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Human Microbiome Sequencing Revenue Market Share by Type (2025-2030)
Table 28. Global Human Microbiome Sequencing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Human Microbiome Sequencing Revenue Market Share by Application (2019-2024)
Table 30. Global Human Microbiome Sequencing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Human Microbiome Sequencing Revenue Market Share by Application (2025-2030)
Table 32. North America Human Microbiome Sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Human Microbiome Sequencing Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Human Microbiome Sequencing Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Human Microbiome Sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Human Microbiome Sequencing Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Human Microbiome Sequencing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Human Microbiome Sequencing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Human Microbiome Sequencing Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Human Microbiome Sequencing Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Human Microbiome Sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Human Microbiome Sequencing Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Human Microbiome Sequencing Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Human Microbiome Sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Human Microbiome Sequencing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Human Microbiome Sequencing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Baseclear B.V. Company Detail
Table 48. Baseclear B.V. Business Overview
Table 49. Baseclear B.V. Human Microbiome Sequencing Product
Table 50. Baseclear B.V. Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 51. Baseclear B.V. Recent Development
Table 52. Beijing Genomics Institute (BGI) Genomics Co., Ltd Company Detail
Table 53. Beijing Genomics Institute (BGI) Genomics Co., Ltd Business Overview
Table 54. Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Product
Table 55. Beijing Genomics Institute (BGI) Genomics Co., Ltd Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 56. Beijing Genomics Institute (BGI) Genomics Co., Ltd Recent Development
Table 57. Charles River Laboratories International Inc. Company Detail
Table 58. Charles River Laboratories International Inc. Business Overview
Table 59. Charles River Laboratories International Inc. Human Microbiome Sequencing Product
Table 60. Charles River Laboratories International Inc. Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 61. Charles River Laboratories International Inc. Recent Development
Table 62. Clinical Microbiomics A/S Company Detail
Table 63. Clinical Microbiomics A/S Business Overview
Table 64. Clinical Microbiomics A/S Human Microbiome Sequencing Product
Table 65. Clinical Microbiomics A/S Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 66. Clinical Microbiomics A/S Recent Development
Table 67. Eurofins Scientific SE Company Detail
Table 68. Eurofins Scientific SE Business Overview
Table 69. Eurofins Scientific SE Human Microbiome Sequencing Product
Table 70. Eurofins Scientific SE Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 71. Eurofins Scientific SE Recent Development
Table 72. GENEWIZ, Inc. Company Detail
Table 73. GENEWIZ, Inc. Business Overview
Table 74. GENEWIZ, Inc. Human Microbiome Sequencing Product
Table 75. GENEWIZ, Inc. Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 76. GENEWIZ, Inc. Recent Development
Table 77. Illumina, Inc. Company Detail
Table 78. Illumina, Inc. Business Overview
Table 79. Illumina, Inc. Human Microbiome Sequencing Product
Table 80. Illumina, Inc. Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 81. Illumina, Inc. Recent Development
Table 82. Novogene Corporation Company Detail
Table 83. Novogene Corporation Business Overview
Table 84. Novogene Corporation Human Microbiome Sequencing Product
Table 85. Novogene Corporation Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 86. Novogene Corporation Recent Development
Table 87. OraSure Technologies, Inc. Company Detail
Table 88. OraSure Technologies, Inc. Business Overview
Table 89. OraSure Technologies, Inc. Human Microbiome Sequencing Product
Table 90. OraSure Technologies, Inc. Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 91. OraSure Technologies, Inc. Recent Development
Table 92. Oxford Nanopore Technologies, Inc. Company Detail
Table 93. Oxford Nanopore Technologies, Inc. Business Overview
Table 94. Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Product
Table 95. Oxford Nanopore Technologies, Inc. Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 96. Oxford Nanopore Technologies, Inc. Recent Development
Table 97. Pacific Biosciences of California, Inc. Company Detail
Table 98. Pacific Biosciences of California, Inc. Business Overview
Table 99. Pacific Biosciences of California, Inc. Human Microbiome Sequencing Product
Table 100. Pacific Biosciences of California, Inc. Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 101. Pacific Biosciences of California, Inc. Recent Development
Table 102. QIAGEN N.V. Company Detail
Table 103. QIAGEN N.V. Business Overview
Table 104. QIAGEN N.V. Human Microbiome Sequencing Product
Table 105. QIAGEN N.V. Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 106. QIAGEN N.V. Recent Development
Table 107. Second Genome, Inc. Company Detail
Table 108. Second Genome, Inc. Business Overview
Table 109. Second Genome, Inc. Human Microbiome Sequencing Product
Table 110. Second Genome, Inc. Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 111. Second Genome, Inc. Recent Development
Table 112. Thermo Fisher Scientific Inc. Company Detail
Table 113. Thermo Fisher Scientific Inc. Business Overview
Table 114. Thermo Fisher Scientific Inc. Human Microbiome Sequencing Product
Table 115. Thermo Fisher Scientific Inc. Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 116. Thermo Fisher Scientific Inc. Recent Development
Table 117. Viome, Inc. Company Detail
Table 118. Viome, Inc. Business Overview
Table 119. Viome, Inc. Human Microbiome Sequencing Product
Table 120. Viome, Inc. Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 121. Viome, Inc. Recent Development
Table 122. CosmosID Company Detail
Table 123. CosmosID Business Overview
Table 124. CosmosID Human Microbiome Sequencing Product
Table 125. CosmosID Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 126. CosmosID Recent Development
Table 127. Leucine Rich Bio Pvt. Ltd. Company Detail
Table 128. Leucine Rich Bio Pvt. Ltd. Business Overview
Table 129. Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Product
Table 130. Leucine Rich Bio Pvt. Ltd. Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 131. Leucine Rich Bio Pvt. Ltd. Recent Development
Table 132. Microba Company Detail
Table 133. Microba Business Overview
Table 134. Microba Human Microbiome Sequencing Product
Table 135. Microba Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 136. Microba Recent Development
Table 137. Microbiome Insights Inc. Company Detail
Table 138. Microbiome Insights Inc. Business Overview
Table 139. Microbiome Insights Inc. Human Microbiome Sequencing Product
Table 140. Microbiome Insights Inc. Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 141. Microbiome Insights Inc. Recent Development
Table 142. Molzym GmbH & Co. KG Company Detail
Table 143. Molzym GmbH & Co. KG Business Overview
Table 144. Molzym GmbH & Co. KG Human Microbiome Sequencing Product
Table 145. Molzym GmbH & Co. KG Revenue in Human Microbiome Sequencing Business (2019-2024) & (US$ Million)
Table 146. Molzym GmbH & Co. KG Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Microbiome Sequencing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Human Microbiome Sequencing Market Share by Type: 2023 VS 2030
Figure 3. Next-Generation Sequencing Features
Figure 4. Traditional Sequencing Technologies Features
Figure 5. Other Features
Figure 6. Global Human Microbiome Sequencing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Human Microbiome Sequencing Market Share by Application: 2023 VS 2030
Figure 8. Genome Analysis Case Studies
Figure 9. Metabolome Analysis Case Studies
Figure 10. Transcriptome Analysis Case Studies
Figure 11. Other Omics Analysis Case Studies
Figure 12. Human Microbiome Sequencing Report Years Considered
Figure 13. Global Human Microbiome Sequencing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Human Microbiome Sequencing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Human Microbiome Sequencing Market Share by Region: 2023 VS 2030
Figure 16. Global Human Microbiome Sequencing Market Share by Players in 2023
Figure 17. Global Top Human Microbiome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Sequencing as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Human Microbiome Sequencing Revenue in 2023
Figure 19. North America Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Human Microbiome Sequencing Market Share by Country (2019-2030)
Figure 21. United States Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Human Microbiome Sequencing Market Share by Country (2019-2030)
Figure 25. Germany Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Human Microbiome Sequencing Market Share by Region (2019-2030)
Figure 33. China Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Human Microbiome Sequencing Market Share by Country (2019-2030)
Figure 41. Mexico Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Human Microbiome Sequencing Market Share by Country (2019-2030)
Figure 45. Turkey Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Human Microbiome Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Baseclear B.V. Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 48. Beijing Genomics Institute (BGI) Genomics Co., Ltd Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 49. Charles River Laboratories International Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 50. Clinical Microbiomics A/S Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 51. Eurofins Scientific SE Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 52. GENEWIZ, Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 53. Illumina, Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 54. Novogene Corporation Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 55. OraSure Technologies, Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 56. Oxford Nanopore Technologies, Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 57. Pacific Biosciences of California, Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 58. QIAGEN N.V. Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 59. Second Genome, Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 60. Thermo Fisher Scientific Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 61. Viome, Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 62. CosmosID Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 63. Leucine Rich Bio Pvt. Ltd. Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 64. Microba Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 65. Microbiome Insights Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 66. Molzym GmbH & Co. KG Revenue Growth Rate in Human Microbiome Sequencing Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies